Benefits are typically more noticeable when correcting an existing deficiency
The simple truth is that there is NO information on the safety or side effects of BPC-157 in humans
BPC-157: Not a Steroid, but a Recovery Powerhouse
The regulatory reality of peptides Rogan's candid discussions inevitably touch on the murky regulatory status of many peptides
Am J Respir Crit Care Med 182(11):13441351 Dorecka M, Siemianowicz K, Francuz T, Garczorz W, Chyra A, Klych A et al (2013) Exendin-4 and GLP-1 decreases induced expression of ICAM-1, VCAM-1 and RAGE in human retinal pigment epithelial cells
Current Research Protocols for Tendon Studies Standard rodent tendon protocols use Achilles transection or partial tendon injury models, with BPC-157 administered intraperitoneally at 10 g/kg or 10 ng/kg once daily, beginning shortly after surgical injury